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G-quadruplex (G4) structural motifs have been linked to transcription
1,2
, replication
3
 and genome 12 
instability
4,5
 and are implicated in cancer and other diseases
6-8
. However, it is crucial to 13 
demonstrate the bona fide formation of G4 structures within an endogenous chromatin context
9,10
. 14 
Herein, we address this via the development of G4 ChIP-seq, an antibody-based G4 chromatin 15 
immunoprecipitation and high-throughput sequencing approach. We find that ~10,000 G4s are 16 
predominantly present in human regulatory, nucleosome-depleted chromatin. G4s were enriched 17 
in the promoters and 5’UTR regions of highly transcribed genes, particularly in genes related to 18 
cancer and in somatic copy number amplifications, such as MYC. Strikingly, de novo and 19 
enhanced G4 formation is associated with increased transcriptional activity as revealed by small 20 
molecule-induced chromatin relaxation and in immortalized versus normal cellular states. Our 21 
findings show for the first time that regulatory, nucleosome-depleted chromatin and elevated 22 
transcription shape the endogenous human G4 DNA landscape. 23 
 24 
Regulatory regions in chromatin are characterized by nucleosome depletion to allow access of 25 
proteins directing gene transcription, replication and epigenetic plasticity
11
. These accessible 26 
regions are quantitative indicators of cellular fate, origin and identity,
12
 yet the underlying DNA 27 
structural features remain largely uncharacterized. G4 DNA structures have recently been 28 
visualized in human cells
13,14
 and directly mapped in purified genomic DNA
15
. Employing G4-29 
promoting conditions, ~700,000 G4-induced polymerase-stalling sequences have been observed 30 
in the human genome in vitro using purified single-stranded DNA as a template for G4-seq, a 31 
high-throughput sequencing method for the discovery of structural features in DNA
16
. G4s have 32 
been computationally predicted to form in replication origins
17,18
 and nucleosome-depleted 33 
regions
19
. Endogenous proteins, such as human ATRX
20
 and XPB/XPD
1
 and yeast Pif-1
21
 and 34 
Rif-1
22
 have been mapped by ChIP-seq to G-rich genomic sequences predicted to adopt G4s in 35 
 2 
vivo, however, direct capture of G4 structure formation at high-resolution within a chromatin 36 
context is missing. 37 
We set out to elucidate the relationship between G4 structure, chromatin and transcription in 38 
human cells. To achieve this, we developed a G4 ChIP-seq protocol employing an engineered G4 39 
structure-specific antibody (BG4)
13
 to map the genome-wide location of G4s in the chromatin of 40 
the spontaneously immortalized, non-oncogenic, human epidermal keratinocyte HaCaT cell line
23
 41 
(Fig. 1, Supplementary Fig. 1). We mapped nucleosome-depleted regions, using Formaldehyde 42 
Assisted Isolation of Regulatory Elements and sequencing (FAIRE-seq)
24
 and Assay for 43 
Transposase Accessible Chromatin and sequencing (ATAC-seq)
25
 (Supplementary Fig. 1) and 44 
determined transcriptional output by RNA-seq. Overall in HaCaT chromatin 10,560 high-45 
confidence G4 ChIP-seq peaks were identified with 87 % conforming to an in vitro observed G4 46 
structural motif (Fig. 1, Supplementary Fig. 2, see method section, ‘G4 motif and enrichment 47 
analysis’)16. Analysis of G4 motifs revealed that 21 % of all G4 ChIP-seq peaks contain G4 48 
motifs, with loop sizes of 1–7 (canonical G4s) (Supplementary Fig. 2)26. Canonical G4s were 49 
enriched more in G4 ChIP-seq peaks than other G4 motifs (Supplementary Fig. 2), e.g. with 50 
longer loops
27
 or bulges in G-tracts
28
. We also validated the G4-structure specific enrichment 51 
observed in the HaCaT G4 ChIP-seq peaks in control experiments by G4 ChIP-qPCR, such as 52 
pre-incubation of BG4 with a G4-forming or single-stranded DNA sequence prior to G4 ChIP 53 
(Supplementary Fig. 3), and by bioinformatic analysis of recurrent MEME-derived motifs and 54 
their density in G4 ChIP-seq regions (Supplementary Fig. 2). Strikingly, most (98 %) G4 ChIP-55 
seq peaks overlapped with regions as defined by the union of FAIRE- and ATAC-seq regions 56 
(Fig. 1b). We considered the possibility that BG4 might simply target the most accessible open 57 
chromatin regions, rather than true G4 sites. To rule out that BG4 enriches the most abundant 58 
accessible chromatin sites, regardless of G4 presence, we overlapped the high-confidence G4 59 
ChIP-seq peak set (10,560) with the 10,560 most accessible FAIRE sites. FAIRE accessibility 60 
was ranked according to q-value for peak enrichment assigned by the MACS2 peak caller. We 61 
found that ~44 % of the G4 ChIP-seq peaks did not overlap with these highly accessible FAIRE 62 
sites but are actually found in relatively less accessible FAIRE sites than the 10,560 most 63 
accessible FAIRE sites. This suggests that chromatin accessibility alone is not sufficient for BG4 64 
binding. We further validated the presence of G4 structures in nucleosome-depleted chromatin 65 
using immunofluorescence microscopy colocalization for BG4 and another G4 antibody (1H6)
14
, 66 
with eu- and heterochromatin markers in HaCaT cells. We found that both antibodies 67 
significantly colocalized with transcriptionally active euchromatin (H3K4me3 and/or RNA Pol2), 68 
 3 
while they showed no significant colocalization with heterochromatin (H3K9me3) 69 
(Supplementary Fig. 4). Collectively, these results demonstrate that G4 formation in human cells 70 
is predominantly restricted to regulatory nucleosome-depleted regions in euchromatin. 71 
Overall, HaCaT G4 ChIP-seq peaks represent about 1 % of all sequences detected by G4-seq
16
 72 
(hereon referred to as Observed Quadruplex sequences) (Supplementary Fig. 5). However, of all 73 
OQs that map to nucleosome-depleted regions in HaCaT cells, only a subset (26 %) overlapped 74 
with G4 ChIP-seq peaks (Supplementary Fig. 5). Importantly, the remaining 74 % OQs not 75 
detected by BG4 in nucleosome-depleted regions showed a comparable representation of G4 76 
motifs (sequence and structure) to the positive G4 ChIP subset (26 %) (Supplementary Fig. 5). 77 
This suggests that additional genomic features/events, besides nucleosome-depletion, are likely to 78 
be important for G4s to form stably in chromatin. While the G4 ChIP-seq peaks are considerably 79 
enriched in promoter and 5’UTR regions, i.e. found more often than expected by random chance, 80 
they are mostly located outside of these regions (Fig. 1c). This raises the possibility that the 81 
transcriptional state of a gene might affect G4 formation in nucleosome-depleted regions. Indeed, 82 
we observed genes (4,522) that display a G4 ChIP-seq peak in their promoter have on average 83 
significantly (p = < 0.0001) higher transcriptional levels than genes (4,345) lacking a promoter 84 
G4 ChIP-seq peak, yet are still found nucleosome-depleted and contain an OQ (Fig. 1d). Since 85 
regulatory proteins shape open chromatin, we anticipated that published ChIP-seq for XPB/XPD
1
 86 
or SP1
29
 that unwind or bind G4s in vitro or NP63 a master regulator of keratinocyte 87 
transcription
30
, would be enriched in the G4 ChIP-seq data. Indeed, a notable enrichment of all, 88 
XPB/XPD (60-fold), SP1 (330-fold) and NP63 (72-fold) high-confidence peaks were observed 89 
in the HaCaT G4 ChIP-seq data, suggesting that these might directly interact with endogenous 90 
G4s (Fig. 1b). In contrast and as anticipated, the H3K9me3 and H3K27me3 ChIP-seq peaks 91 
showed no correlation with the G4 ChIP-seq sites (Fig. 1b). Taken together, these results suggest 92 
that the chromatin context predominantly restricts G4 formation to regulatory nucleosome-93 
depleted regions associated with genes showing elevated transcription. This is consistent with 94 
transcriptional up-regulation of predicted G4-forming genes observed in G4 helicase-deficient 95 
(i.e. WRN, BLM) human cells
31
 and binding sites of G4 helicases XPB, XPD and the yeast PIF-1 96 
homolog, Pfh1, in transcriptionally active chromatin
1,32
. Fig. 1a shows example profiles for G4 97 
ChIP-, ATAC- and FAIRE-seq aligned with peak profiles that mark OQs for the SRC and MYC 98 
oncogenes, that have previously been suggested to be regulated by G4s
2,10
. Here, we directly 99 
confirm the presence of G4 structures in the nuclease hypersensitivity element of the oncogenes 100 
MYC, and in the upstream element and gene body of SRC (Fig. 1a). Recently, we reported an 101 
 4 
enrichment of OQs at cancer-related genes and somatic copy number alterations (SCNAs)
16
, we 102 
now extend these findings to show endogenous G4 (i.e. G4 ChIP) enrichment in cancer-related 103 
genes, such as MYC, TP53, JUN, HOXA9, FOXA1, RAC1 (Supplementary Fig. 6, Supplementary 104 
Table 1) and  SCNAs (Supplementary Fig. 7, Supplementary Table 2). Among all cancer-related 105 
SCNA amplifications and oncogenes, MYC shows the highest G4 ChIP density, supporting an 106 
already suggested role
33
 for G4 structures in cancer progression (Supplementary Fig. 6, 7).  107 
We reasoned that if G4 structures are coupled to nucleosome-depletion and their transcriptional 108 
status, then changing the chromatin landscape would cause a concomitant shift in the G4 profile. 109 
We induced chromatin relaxation of HaCaT cells using the histone deacetylase (HDAC) inhibitor 110 
Entinostat
34
 to stabilize transcriptionally active chromatin through promoter-specific histone 111 
H3K27 acetylation
35
. HaCaT cells treated with 2 µM Entinostat for 48h
35
 were analyzed by G4 112 
ChIP-, ATAC-, and RNA-seq (Fig. 2, Supplementary Fig. 8). Genome-wide changes in G4 ChIP-113 
seq peaks, open chromatin and mRNA levels were quantified bioinformatically by Differential 114 
Binding Analysis (DBA)
36
 (Fig. 2a, b, Supplementary Fig. 8). HDAC inhibition resulted in the 115 
appearance of 4,117 new, or more intense G4 ChIP-seq sites and 7,970 open chromatin regions 116 
(Fig. 2a, b). The emergent 4,117 G4 ChIP-seq sites are located in new or pre-existing 117 
nucleosome-depleted regions, e.g. SIGIRR, GRIN1 and a non-coding region (Fig. 2a, c), however, 118 
importantly none of these sites were found in nucleosome-depleted regions in closed chromatin 119 
after Entinostat treatment (Fig. 2a, c). Next, we explored the relationship between G4s identified 120 
in promoters of nucleosome-depleted regions and their transcriptional status of associated genes 121 
by comparing RNA-seq data to G4 ChIP-seq peaks between untreated and Entinostat treated 122 
cells. Consistent with the outcome in untreated cells (Fig. 1d), we observed that genes with OQs 123 
in promoters that overlap with both a G4 ChIP-seq peak and an ATAC-seq peak have on average 124 
a significantly higher transcriptional output (P<0.0001) than promoters without a G4 ChIP-seq 125 
peak in Entinostat treated HaCaTs (Supplementary Fig. 8). Importantly, for promoters that 126 
showed a new or larger G4 ChIP-seq peak, but no significant change in their open chromatin state 127 
after Entinostat treatment, transcriptional output also increased in comparison to their untreated 128 
state (P<0.0001) (Fig. 2d). This indicates that there is a positive and dynamic relationship 129 
between G4 structure and transcriptional activity independent of the degree of chromatin 130 
accessibility (Fig. 2d), and further suggests that G4s epigenetically mark the genome, whereby 131 
four-stranded structure formation rather than the underlying sequence per se is directly linked to 132 
elevated transcription. 133 
 5 
We next investigated how an altered cellular state results in chromatin, G4 and transcriptional 134 
changes by comparing normal human epidermal keratinocytes (NHEKs) and their spontaneously 135 
immortalized counterpart, the HaCaT cell line. Using G4 ChIP-seq, ATAC/FAIRE-seq (Fig. 3, 136 
Supplementary Fig. 9), we found that while NHEKs exhibit 85,668 more nucleosome-depleted 137 
regions than HaCaT cells (Supplementary Fig. 9), there are less ChIP-seq peaks in NHEKs as 138 
compared to HaCaTs (1,496 vs. 10,560) (Fig. 3b). The G4 ChIP-seq peaks identified in HaCaT 139 
cells (8,478, 80%), but absent from NHEKs, were found located entirely within nucleosome-140 
depleted regions common to both cell lines (Fig. 3a), suggesting that additional mechanism(s), 141 
beyond having a nucleosome-depleted environment, control G4 formation in NHEKs relative to 142 
HaCaTs. Indeed, genes comprising promoter G4 ChIP-seq peaks with OQs that were present 143 
exclusively in HaCaTs showed an overall increase in transcription as compared to genes 144 
containing promoter G4 ChIP-seq peaks common to both cellular states (Fig. 3c, Supplementary 145 
Fig. 9). 146 
It is noteworthy that we identified G4s in many cancer genes, for example MYC, PTEN and 147 
KRAS, in immortalized HaCaT cells but not in NHEKs (Fig. 3a), suggesting a link between 148 
increased proliferative capacity/immortalization
23
 and G4s. We determined whether the increased 149 
presence of G4s in HaCaT cells versus NHEKs was also reflected in the G4 foci observed in 150 
nuclei visualized by BG4 immunofluorescence microscopy
13
. Consistent with our G4 ChIP-seq 151 
data, we found that HaCaT cells showed ~4-fold (20 ± 8 vs. 5 ± 2) more G4 foci than NHEKs 152 
(Fig. 3d, Supplementary Fig. 8). We have previously shown that the G4-selective small molecule 153 
pyridostatin (PDS) binds G4 structures, inducing a transcription- and replication-dependent DNA 154 
damage response, thus inhibiting cell growth
10,37
. We therefore investigated PDS sensitivity of 155 
HaCaTs vs. NHEKs. We found that HaCaTs are ~7-times more sensitive to growth inhibition by 156 
PDS as determined by GI50 (0.9 ± 0.3 vs. 6.5 ± 0.4 µM) values than NHEKs and is consistent 157 
with an increased number of G4s in HaCaTs (Fig. 3e). This increased abundance of G4s mirrors 158 
our previous observation that G4 structures can be more prevalent in cancer as compared to 159 
matched normal tissue
38
 and suggests a potential rationale for selective cancer intervention by G4 160 
targeting.  161 
Here, we provide the first high-resolution genome-wide map of G4 structures in human 162 
chromatin. The number of G4 ChIP-seq sites (10,000) is substantially lower than predicted by 163 
computation
26
 or observed by G4-seq
16
, and likely reflects the generally suppressive role of 164 
heterochromatin for G4 formation in human cells (e.g. nucleosome density), which may be 165 
different in other species
39
. More G4 ChIP-seq peaks are observed than BG4 IF foci
13
 and is 166 
 6 
explained by the higher sensitivity and resolution of the ChIP-seq method. We conclude that G4s 167 
show hallmarks of dynamic epigenetic features in chromatin primarily found in regulatory, 168 
nucleosome-depleted regions and correlated with genes showing elevated transcription (Fig. 4). 169 
While small-molecule G4 stabilization can promote a DNA damage response
10,40
 and can cause 170 
transcriptional repression
2
, our study suggests that endogenous G4 structures in promoters are 171 
ordinarily linked to elevated transcriptional activity. We have also discovered that the 172 
endogenous G4 landscape is dynamically altered depending on chromatin relaxation or cell 173 
status; and that G4s are particularly enriched in cancer-related genes and regions predisposed to 174 
amplification in cancer. Our study further illustrates the potential of the G4 structural motif as a 175 
bona fide target for disease, diagnosis and intervention. 176 
URLs Reprints and permissions information are available at www.nature.com/reprints. A sample 177 
sheet describing the detailed experimental design is available at https://github.com/sblab-178 
bioinformatics/dna-secondary-struct-chrom-lands. Details of data analysis have been deposited at 179 
https://github.com/sblab-bioinformatics/dna-secondary-struct-chrom-lands. Lists of oncogenes 180 
and tumor-suppressor genes were obtained respectively from the COSMIC database 181 
(http://cancer.sanger.ac.uk/census).
41
 and tumor suppressor gene database 182 
(http://bioinfo.mc.vanderbilt.edu/TSGene/)
42
. Peak correlations were performed using the bedtool 183 
package (bedtools.readthedocs.org). 184 
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Figure 1 G4s are prevalent in regulatory chromatin regions. (a) Example genome browser 303 
screenshots for SRC and MYC. Tracks are shown for HaCaT G4 ChIP-seq (top, red) and control 304 
input below (red); regulatory chromatin sites by ATAC and FAIRE-seq (tracks 3 and 4, black) 305 
and G4-seq peaks (Pyridostatin derived OQs) (purple, % mismatches in reads aligned) on the 306 
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reverse (-ss) and forward strand (+ss)
16
, respectively (tracks 5 and 6, purple). (b) Enrichment and 307 
peak overlap of HaCaT G4 ChIP-seq peaks with different ENCODE protein ChIP-seq data sets
43
; 308 
s.d. (N = 3) (c) Enrichment of HaCaT G4 ChIP-seq peaks relative to what is expected by 309 
randomly shuffling G4 ChIP-seq peaks in OQs and the absolute proportion of G4 ChIP-seq peaks 310 
across different genomic features (N = 3, error bars indicate standard deviation). (d) Distribution 311 
of mRNA levels (displayed in transcripts per million, log10 scale) are shown for promoter 312 
associated genes (4,345) that feature an ATAC-seq peak and an OQs signature in comparison to 313 
genes (4,522) that exhibit a promoter G4 ChIP peak, ATAC-seq and OQs feature in HaCaTs. 314 
**** indicates significance (P<0.0001; unpaired two-tailed T-test).  315 
 316 
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 317 
Figure 2 Chromatin relaxation increases G4 prevalence in regulatory chromatin regions. 318 
(a) Genomic view of SIGIRR, GRIN1 and a non-coding region (chr8:143,274,210) showing 319 
overlap between new G4 sites and regulatory chromatin in Entinostat-treated cells. The SKI 320 
promoter (right) exemplifies a gene not significantly changed in G4 ChIP-seq or nucleosome-321 
depletion. Top two tracks: untreated HaCaT cells with G4 ChIP-seq/input (red) and ATAC-seq 322 
(black). Middle three tracks: Entinostat-treated HaCaT cells, G4 ChIP-seq/input HDACi (red), 323 
ATAC-seq HDACi (black). Bottom two tracks- OQs (PDS-derived, purple), reverse (-ss) and 324 
forward strand (+ss)
16
, respectively. (b) Differential Binding Analysis (DBA) showing significant 325 
 12 
(FDR <0.05) differences in G4 ChIP-seq and ATAC-seq peaks between Entinostat-treated versus 326 
untreated HaCaT cells. Red dots represent peaks where G4 ChIP peaks or nucleosome-depletion 327 
(ATAC) is significantly changed in Entinostat-treated compared to untreated HaCaT cells. Red 328 
and black arrows indicate increase or decrease of G4 formation and changes in nucleosome-329 
depletion (ATAC-seq), respectively. (c) Peak overlap between increased and decreased G4 ChIP-330 
seq peaks and open chromatin regions, derived from (b). (d) Differential gene expression for 331 
promoter-associated genes that i) do not contain high-confidence G4 ChIP-seq peaks, but have at 332 
least one OQs and ATAC-seq peak unaltered in size between conditions (1,734 promoters), ii) as 333 
in i) but contains at least one high-confidence G4 ChIP-seq peak shared between conditions and 334 
do not contain G4 ChIP-seq peaks significantly increased in size (3,627 promoters), or iii) as in i) 335 
but contains G4 ChIP-seq peaks significantly increased in size across conditions (373 promoters). 336 
(**** P<0.0001; ordinary one-way ANOVA). 337 
 338 
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 339 
Figure 3 G4 prevalence is significantly increased in immortalized compared to normal 340 
human epidermal keratinocytes. 341 
(a) Genomic view of PTEN, MYC, KRAS, and TSEN34 in HaCaT and NHEK cells. Tracks are G4 342 
ChIP-seq/input HaCaT (top two, red), ATAC-seq HaCaT (third, black), G4 ChIP-seq/input 343 
NHEK (fourth and fifth, red), ATAC-seq NHEK (sixth, black), OQs (PDS-derived, bottom two 344 
tracks in purple) on the reverse (-ss) and forward strand (+ss)
16
, respectively. (b) Overlap of G4 345 
ChIP-seq peaks between HaCaT and NHEK (top), and overlap between G4 ChIP-seq peaks and 346 
shared open chromatin regions (ATAC/FAIRE) (bottom); while both NHEKs and HaCaTs share 347 
G4 and active chromatin regions, NHEKs have ~7-fold less G4s. (c) mRNA levels for promoter-348 
associated genes featuring i) a G4 ChIP and ATAC-seq peak and an OQ signature (503 genes) 349 
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common to NHEK and HaCaT cells and ii) a unique G4 ChIP/ATAC/OQs peak signature in 350 
HaCaT cells vs. NHEK (3,617 genes) (**** P<0.0001, unpaired two-tailed T-test). (d) 351 
Quantification of immunolocalization (see Supplementary Fig. 9) showing the average number of 352 
BG4 foci per cell increases in HaCaT vs. NHEK cells. 109 and 333 HaCaT nuclei and 186 and 353 
326 NHEK nuclei were analyzed (N = 2). Error bars indicate standard deviation and (**** 354 
P<0.0001, unpaired two-tailed T-test). (e) Growth inhibition response curves for treatment with 355 
PDS (n = 6, error bars indicate standard deviation). The concentration to give 50 % growth 356 
inhibition (GI50) is indicated for HaCaTs (light grey curve) and NHEKs (dark grey curve). 357 
 358 
 359 
Figure 4 G4 DNA formation in chromatin. G4 DNA formation is highly dependent on 360 
chromatin structure and is frequently found in regulatory nucleosome-depleted regions in 361 
proximity to transcription start sites of genes that undergo elevated transcription. 362 
 363 
Online Methods  364 
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Cell culture 365 
HaCaT cells were kindly provided by Prof. Fiona Watt and cultured in Dulbecco's Modified 366 
Eagle Medium (Thermofisher, DMEM, cat. no. 41965-039) supplemented with 10% fetal bovine 367 
serum (FBS) (Thermofisher). U2OS cells were cultured in DMEM (Thermofisher, cat. no. 41966-368 
029) supplemented with 10 % FBS. Normal human epidermal keratinocytes, pooled from 369 
multiple donors, were purchased from Thermofisher and cultured in EpiLife medium 370 
supplemented with human keratinocyte growth supplement (HKGS) (Thermofisher). Cell line 371 
genotypes were certified by the supplier and STR profiling. Cells lines were confirmed 372 
mycoplasma-free by RNA-capture ELISA.  373 
G4 ChIP-seq protocol and library preparation 374 
20 million cells were fixed in DMEM (cat no. 41965-039) containing 1 (v/v) % formaldehyde and 375 
10 (v/v) % FBS for 15 min at room temperature (RT) followed by quenching with 0.13 M glycine 376 
at RT for 10 min. Cells were washed in ice-cold PBS and chromatin isolated and prepared as 377 
described by the manufacturer (Chromatrap). Chromatin was sonicated using a Bioruptor Plus 378 
(Diagenode). 250 µL of lysed nuclei suspension was sonicated for 25 cycles (30s on/60s off) in 379 
1.5 mL TPX sonication tubes (Diagenode) to an average DNA size of 100–500 bp. For chromatin 380 
immunoprecipitation (ChIP), 2.5 µL chromatin was blocked at 16 C for 20 min in 44.5 µL 381 
intracellular salt solution (25 mM HEPES pH 7.5, 10.5 mM NaCl, 110 mM KCl, 130 nM CaCl2, 382 
1 mM MgCl2), containing 1 (w/v) % bovine serum albumin (BSA) (Sigma cat. no. B4287), 383 
referred as blocking buffer. Recombinant BG4 and control phage display antibody were 384 
expressed as described
14
. 200 ng of recombinant BG4 or control phage display antibody were 385 
then added and incubated for 1h at 16 C. Meanwhile, 90 µL beads (SIGMA-ALDRICH Anti-386 
FLAG® M2 Magnetic Beads, cat. no. M8823) were washed 3x with 900 µL blocking buffer and 387 
stored on ice in 900 µL blocking buffer (blocked bead solution). Next, 50 µL of blocked bead 388 
solution was added to the ChIP reaction (final volume 100 µL) and incubated for 1h at 16 C with 389 
rotation. Beads were magnetically captured and the supernatant discarded and the beads washed 390 
three times in 200 µL wash (4 C) buffer (10mM Tris pH 7.4, 100mM KCl, 0.1 (v/v) % Tween 391 
20) with manual agitation. Beads were resuspended in 200 µL wash buffer and incubated on a 392 
rotating platform at 37 C for 10 min. The warm wash procedure was repeated, and beads 393 
subjected to a final wash (4 C) before removing the supernatant and re-suspension in 75 µL of 394 
elution buffer, containing 1x TE buffer with 20 µg proteinase K (Thermofisher). Elution was 395 
performed at 37 C for 1h and at 65 C for additional 2h. Beads were magnetically captured and 396 
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eluted DNA purified from supernatant using a MinElute kit (Qiagen). For each technical 397 
replicate, eluted DNA from four ChIP reactions were combined and the pool subjected to Nextera 398 
library preparation as described by the manufacturer (Illumina, cat. no. FC-121-1030). Three 399 
independent technical replicates were pulled-down and sequenced for each of the two biological 400 
replicates.  401 
G4 ChIP-qPCR 402 
Purified and sonicated DNA (as above) were used to quantify G4 enrichment via qPCR, using 403 
Fast SYBR PCR mix (Applied Biosystems, UK), with a BioRad CFX96 quantitative PCR 404 
machine. Cycling conditions were 95 C for 20 s followed by 40 cycles of 3 s at 95C and 30 s at 405 
60C. We employed primer pairs that target G4 ChIP positive and negative regions 406 
(Supplementary Table 3). Relative enrichments were derived with respect to their inputs and 407 
normalized to a G4-free enhancer region associated with the ESR1 gene (Supplementary Table 3). 408 
RNase A has been shown to digest G4 RNA
13,44,45
 and G4 DNA/RNA hybrids
45
. For DNase or 409 
RNase A treatments, 2 U of TURBOTM DNase (2 U/µL; Thermo Fisher Scientific) or 1µg of 410 
RNase A (1 mg/mL, Ambion® Thermo Fisher Scientific) were added to the ChIP blocking buffer 411 
chromatin mixture and chromatin digestion, instead of chromatin blocking, was performed at 37 412 
°C for 20 min.   413 
Epigenome mapping 414 
FAIRE-seq was performed essentially as described, with minor modifications
46
. Cell lysis was 415 
performed using a PRECELLYS® 24 homogeniser and phenol-chloroform extraction was 416 
performed using Heavy Phase-Lock Gels (5-PRIME™). Transposase-accessible chromatin using 417 
sequencing (ATAC-seq) was performed essentially as described, with minor modifications
25
. 418 
Tagmented DNA samples were amplified (11 PCR cycles) using the Nextera index kit (Illumina, 419 
cat. no. FC-121-1011) and open chromatin fractions were size selected (190–300 bp) via 2 (w/v) 420 
% agarose E-Gel® SizeSelect™ gels (Themofisher). Total RNA for RNA-seq experiments was 421 
extracted using the RNeasy kit (Qiagen, cat. no. 74104), following the manufacturer’s 422 
instructions. RNA-seq libraries were generated using the Illumina Truseq RNA HT (stranded 423 
mRNA) kit (cat. no. RS-122-2103). Overall, 18 G4 ChIP-seq, 18 ATAC-seq, 4 FAIRE-seq and 424 
12 RNA-seq libraries were made (Supplementary Fig. 1). All epigenome libraries were sequenced 425 
in single-end or paired-end using 75 bp reads and the NextSeq500 platform.  426 
Data analysis  427 
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Mapping, peak calling and peak processing. Raw fastq reads were trimmed to remove adapter 428 
contamination and aligned to the human reference genome version hg19 using cutadapt
47
 and 429 
bwa
48
, respectively. Reads with a mapping quality below 10 and marked as positional duplicates 430 
were excluded from further analysis. FAIRE-seq, ATAC-seq and G4-ChIP peaks were mapped 431 
using MACS2.0
49
. RNA-seq reads were aligned to the human reference genome with tophat2
50
. 432 
The Galaxy cistrome platform
51
 was employed to process MACS2.0 called peak intervals and to 433 
generate high-confidence peak overlaps between biological replicates and area-proportional Venn 434 
diagrams. Find Individual Motif Occurrences (FIMO)
52
 analysis was used to quantify the density 435 
of the Multiple Em for Motif Elicitation (MEME)
53
 motifs in the high-confidence G4 ChIP-seq 436 
data (HaCaT).  437 
Differential gene expression. Gene expression levels were quantified as transcripts per million 438 
(TPM). Differentially expressed genes between i) HaCaT treated with Entinostat and untreated 439 
HaCaT and ii) NHEK vs HaCaT were identified using with the Bioconductor package edgeR 440 
(FDR < 0.05; fold change > 1.5)
54
. 441 
G4 transcriptional analysis. Promoter transcription start site (TSS) coordinates, 1kb (+/-) from 442 
TSS, were generated for 22,483 genes using hg19. To reveal absolute gene expression values 443 
(TPM, transcripts per million) for promoters with and without a G4 ChIP-seq signature, we 444 
divided promoters into two categories: 1) promoters that overlap with at least one high-445 
confidence ATAC-seq peak, at least one OQs (potassium- and PDS-induced) and that overlap 446 
with at least one high-confidence G4 ChIP-seq peak, and 2) promoter regions as in 1) that do not 447 
overlap with the high-confidence G4 ChIP-seq data set of untreated HaCaTs (command intersect, 448 
subtract bedtools package).  449 
Differential gene expression levels for promoter-associated genes were prepared into 3 subsets as 450 
follows: Promoters that 1) do not overlap with G4 ChIP-seq peaks, but have at least one OQs and 451 
ATAC-seq peak unaltered in size (log2 fold change = -0.6-to-0.6, FDR<0.05 differential binding 452 
analysis
36
) between untreated and Entinostat treated HaCaTs, 2) as in 1) but do not overlap with 453 
G4 ChIP-seq peaks significantly increased in size for Entinostat treated vs. untreated HaCaTs and 454 
overlap with at least one high-confidence G4 ChIP-seq peak shared between untreated and 455 
Entinostat treated HaCaTs, or 3) as in 1) but overlap with G4 ChIP-seq peaks significantly 456 
increased in size (log2 fold change = >0.6, FDR<0.05 differential binding analysis
36
) for 457 
Entinostat treated vs. untreated HaCaTs (command intersect, subtract bedtools package). **** 458 
indicates significance (P<0.0001; ordinary one-way ANOVA). 459 
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Epigenome enrichment analysis. ChIP-seq data from the ENCODE project was retrieved from the 460 
NCBI’s GEO repository as follows: XPB/XPD (GSE44849); SP1 (ENCSR991ELG; 461 
ENCSR000BJX; ENCSR000BHK); H3K9me3 (ENCSR000EYF; ENCSR000ARN; 462 
ENCSR000APE); H3K27me3 (ENCSR000EWB; ENCSR000DWU; ENCSR000DUE); CTCF 463 
(ENCSR000DWX; ENCSR000EGM; ENCSR000DUG); DeltaNp63 (GSE32061). Overlap 464 
between the high confidence HaCaT G4 ChIP-seq peak file and the ENCODE ChIP-seq data sets 465 
was tested using the Galaxy cistrome platform
51
. Common high confidence ENCODE ChIP-seq 466 
peak files across the three different cell lines were calculated, if applicable (see GEO accession 467 
numbers). ENCODE ChIP-seq peak files were randomly shuffled (N = 6) across the genome and 468 
potential overlaps tested with the G4 ChIP-seq peak file (command shuffleBed of the bedtools 469 
package). Enrichments between G4 ChIP-seq and ENCODE ChIP-seq data sets were calculated 470 
from the ratio of the direct overlaps with the randomly shuffled overlaps. 471 
G4 ChIP-seq peak annotation and enrichment analysis. PAVIS
55
 was used to annotate the HaCaT 472 
G4 ChIP-seq peaks. The G4 ChIP-seq file was randomly shuffled across a file containing all OQs 473 
(potassium and PDS induced) (command shuffleBed of the bedtools package) three independent 474 
times and their genomic annotations retrieved via PAVIS, respectively. To calculate enrichments 475 
of annotated features, ratios of the annotated G4 ChIP-seq proportions were performed with the 476 
proportions of the randomly shuffled features (N = 3). 477 
G4 motif and enrichment analysis. Sequences within peak regions were analyzed by regular 478 
expression matching and assigned to one of the following classes: Loop size 1–3, 4–5 and 6–7: 479 
sequences with at least one loop of the respective length; long loop: sequences with a G4 with 480 
any loop of length >7 (up to 12 for any loop and 21 for the middle loop); simple bulge: sequences 481 
with a G4 with a bulge of 1–7 bases in one G-run or multiple 1-base bulges; 2-tetrads / Complex 482 
bulge: sequences with a G4s with two G-bases per G-run or several bulges of 1–5 bases; and 483 
other: other G4-types that do not fall into the former categories. Sequences in each peak were 484 
assigned to these classes in a hierarchical fashion: for instance, if a sequence matched both the 485 
Loop 1–3 and Long loop categories, it was assigned to the former most category, in this case 486 
Loop 1–3. The fold enrichment analysis was calculated by comparing actual counts for each class 487 
within peak regions to counts of the same peak regions after random reshuffling throughout the 488 
genome using the bedtools shuffle command. Results are shown as the average of 10 489 
randomizations, and the fold enrichment bar plot displays the ratio of real counts divided by 490 
average random counts. For fold enrichment analysis of G4 motifs compared to similar motifs 491 
with lower G4 forming potential, we compared respectively: 1) G4 with 4 G-runs of at least 3 Gs 492 
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each and loop size 1–7 (G3+L1–7) compared to a similar motif with 3 G-runs of at least 3 Gs each 493 
and loop size 1–7; 2) as 1), but with loop length 1–12 (G3+L1–12); 3) as 1), but with G-runs of 2 Gs 494 
each, i.e. 2-tetrads (G2L1–7); 4) canonical G-quadruplex motifs as in 1) (G3+L1–7) but with a single 495 
bulge of 1–7 bases (GGH1–7G, with H=A,T or C) in only one G-run compared to a similar motif 496 
with a single G (H1–2GH1–2) instead of the bulge motif; 5) same G-quadruplex as in 3) (G2L1–7) 497 
compared to a similar motif with one G-run having a single G (H1–2GH1–2). 498 
Cancer-related gene analysis. After remapping to hg19, 555 oncogenes and 1211 tumor 499 
suppressors (Supplementary Table 1) were considered. The occurrence of ChIP-seq peaks in each 500 
gene was determined and compared to the occurrence within not annotated as cancer genes nor 501 
tumor-suppressors. To account for different region size, the peak density was calculated as 502 
number of peaks per Megabase (Mb). Peaks occurring within the gene body (i.e., exons + introns) 503 
and in proximal promoter regions (i.e., 3000 bases upstream of the transcription start site) were 504 
counted separately. P-values for statistical testing were calculated with the non-parametric 505 
Wilcoxon rank sum test (implemented as wilcox.test() function in the R software). 506 
SCNAs analysis. Somatic copy number alteration (SCNA) regions associated with cancer 507 
(n=108), either amplifications (n=54) or deletions (n=54), (i.e. copy number gains or losses of 508 
any length and amplitude), were obtained from the Cancer Genome Atlas Pan-Cancer dataset
56
. 509 
ChIP-seq peak abundance in each region was compared to the occurrence of randomly reshuffled 510 
peak regions (5 different randomization) in a similar manner to the G4 motif enrichment analysis. 511 
To account for different region sizes, peak density was calculated as the number of peaks per 512 
megabase (Mb). For visual comparison, we also determined the average genome-wide peak 513 
density per Mb (avg_density = 3.91), calculated as total number of peaks divided by the effective 514 
genome size (2.7x10
9
 for hg19), multiplied by 1,000,000 bp (Supplementary Table 2).  515 
Immunofluorescence microscopy 516 
BG4 immunostaining and fluorescence microscopy for the HaCaT and NHEK cells were 517 
performed as previously described
13
. All secondary or tertiary antibodies were obtained from 518 
Thermofisher unless otherwise stated. In brief, cells were fixed with 2 (v/v) % formaldehyde in 519 
PBS, permeabilized with 0.1 (v/v) % Triton X100 in PBS, and blocked with 2 (w/v) % Marvel 520 
milk (Premier Foods plc) in PBS. After blocking, cells were incubated with BG4 followed by 521 
incubation with secondary Rabbit -FLAG (cat. no. 2368, Cell Signaling Technology) and 522 
tertiary goat -rabbit conjugated with Alexa-594 (cat. no. A11037) at 37 °C in a humid chamber 523 
for 1h each. Coverslips were mounted on Prolong Gold/DAPI Antifade (Thermofisher). Digital 524 
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images were recorded using a DP70 camera (Olympus) on an Axioskop 2 Plus microscope 525 
(Zeiss) and analyzed with Fiji
57
. 200–300 nuclei were counted per condition and standard 526 
deviations calculated from two biological replicates. Frequency distribution graphs were plotted 527 
using GraphPad Prism (GraphPad Software Inc.). 528 
For BG4 or 1H6 colocalization studies with H3K4me3, H3K9me3 and RNA polymerase II, 529 
HaCaT cells were grown to 50% confluency on # 1.5 glass coverslips. Cells were fixed and 530 
permeabilized as above, treated with 50 μg RNase A for 30 min at 37 °C and incubated in 531 
blocking buffer for 1h at 37 °C (PBS/ 0.5% normal goat serum, 0.1% Tween 20). For BG4 532 
studies, coverslips were incubated with BG4 (10 nM) for 1h at 37 °C, washed three times for 5 533 
min with PBST and incubated 37 °C for 1h with rabbit -FLAG 1:800 (cat. no. 2368, Cell 534 
Signalling Technology) and mouse -H3K9me3 1:200 (Clone CMA304)58 or mouse -H3K9me3 535 
1:200 (clone CMA318)
59
 or mouse -RNA polymerase II carboxy terminal-domain (clone 536 
CMA601) 1:200
60
. For 1H6 studies, coverslips were incubated with mouse -quadruplex DNA 537 
(cat. no. Ab00389-1.1, Absolute Antibody) and rabbit -H3K9me3 1:200 (cat. no. 9751, Cell 538 
Signaling Technology) or rabbit -H3K4 me3 1:500 (cat.no. 07-523, Upstate) for 37 °C for 1h. 539 
Subsequently, all coverslips were washed as described and incubated for 30 min at 37 °C with the 540 
following Alexa Fluor conjugated antibodies: goat -rabbit Alexa-488 (cat. no. A-11034) and 541 
goat -mouse Alexa-555 (cat. no. A-21424) for BG4 studies and goat -mouse Alexa-488 (cat. 542 
no. A-11001) and goat -rabbit Alexa-555 (cat. no. A-21429) for 1H6 studies. DAPI counterstain 543 
was included in the final antibody incubation. Following washing, all coverslips were mounted 544 
onto Superfrost Plus slides (cat. no. 4951PLUS, Thermofisher) with Vectashield antifade 545 
mounting media (cat. No. H-1000, Vector Laboratories Ltd.). Three biological replicates were 546 
performed.  547 
Confocal z-stack images (15 steps) were acquired using a Leica TCS SP8 microscope with a HC 548 
PL APO CS2 1.4NA 100X oil objective (Leica Microsystems), in bidirectional mode, at a scan 549 
speed of 400 Hz and sampling rate of 0.06 μm x 0.06 μm x 280 μm. The 405 nm diode laser was 550 
used to excite the DAPI channel (at 405 nm) and the white light pulsed laser (SuperK 551 
EXTREME, NKT Photonics) was used to excite secondary antibody fluorophores (at 555 nm and 552 
488 nm). Fluorescence detection was performed in sequential acquisition mode with hybrid 553 
detectors (Leica HyD Photon Counter) at the collection wavelength ranges of 490–535 nm, 565–554 
630 nm and 410-485 nm for Alexa Fluor 488, 555 and DAPI respectively. The pinhole was set to 555 
one Airy unit and laser power and gain settings were consistent between replicates. Five to six Z-556 
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stacks were obtained per replica representing 60–160 cells each. Representative images were 557 
processed using Image J
61
/Fiji and Photoshop (Adobe Systems Inc) software and assembled using 558 
Adobe Illustrator CS4.  559 
Colocalization analysis was performed using an automated workflow in MATLAB (R2015b, 560 
Mathworks Inc.) with a link to Image J through MIJ
62
. First, the nuclear region was isolated by 561 
blurring the DAPI channel with a 3D Gaussian (radius 0.2μm) and Otsu thresholding (stack 562 
histogram). Noise reduction of the signal of each colocalization channel was performed using the 563 
PureDenoise plugin (ImageJ)
63
 and isolated by removing background with a rolling ball approach 564 
(radius 2µm) and Otsu thresholding. The corrected first Mander’s overlap coefficient (M1diff) 565 
corresponds to the difference between the percentage of the G4 antibody (BG4 or 1H6) signal 566 
that colocalizes with euchromatin, heterochromatin or gene promotor signal; the expected value 567 
for randomly distributed signal was calculated on the isolated signal. Finally, a two-way t-test 568 
was performed for each condition across the mean values of M1diff across the three biological 569 
replicates
64
, and corrected for multiple hypothesis testing using the Bonforroni correction (n=5). 570 
Graphs were created using GraphPad Prism version 6.00. 571 
Small molecule treatment and growth inhibition analysis 572 
HaCaT cells were treated with 2 µM Entinostat (E5477-5 mg, Cambridge Bioscience) for 48h at 573 
30% confluency in 150 mm tissue culture dishes prior to G4 ChIP fixation procedure or ATAC-574 
seq preparation, or in 6-well plates to generate four technical replicates for RNA-seq preparation. 575 
The concentration to inhibit by 50% cell growth (GI50) induced by PDS was quantified using the 576 
end point Cell Titre Glo assay (Promega). Briefly, 4000 HaCaT and NHEK cells were seeded in a 577 
96-well white plates (Nunc) for 18h prior to small molecule treatment. Cells were then treated 578 
l Titer 579 
Glow for 1h at room temperature and luminescence was measured using a PHERAstar FS 580 
microplate reader (BMG LabTech). Cell survival curves were plotted and GI50 values were 581 
calculated using GraphPad Prism (GraphPad Software Inc.). Error bars represent variability 582 
within 6 replicates. 583 
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